MAPT and Alzheimer disease: Taken together, these data indicate that TBN produces its therapeutic benefits in 3×Tg-AD mice through effectively inhibiting the expressions of APP and PS1 and preventing the hyperphosphorylation of tau in the hippocampal tissues.